Intratumoral, rather than stromal, CD8+ T cells could be a potential negative prognostic marker in invasive breast cancer patients
Open Access
- 22 January 2019
- journal article
- research article
- Published by Elsevier BV in Translational Oncology
- Vol. 12 (3), 585-595
- https://doi.org/10.1016/j.tranon.2018.12.005
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Intratumoral regulatory T cells as an independent predictive factor for pathological complete response to neoadjuvant paclitaxel followed by 5-FU/epirubicin/cyclophosphamide in breast cancer patientsBreast Cancer Research and Treatment, 2012
- CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancerBreast Cancer Research, 2012
- The comprehensive assessment of local immune status of ovarian cancer by the clustering of multiple immune factorsClinical Immunology, 2011
- Immune microenvironments in solid tumors: new targets for therapyGenes & Development, 2011
- An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancerBreast Cancer Research and Treatment, 2010
- Generation of functional CD8+ T Cells by human dendritic cells expressing glypican-3 epitopesJournal of Experimental & Clinical Cancer Research, 2010
- In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal CancerJournal of Clinical Oncology, 2009
- Predominant infiltration of macrophages and CD8+ T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancerCancer, 2008
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002